Dr. Mohamed Eltemamy, MD
Claim this profileCleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Affiliated Hospitals
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Clinical Trials Mohamed Eltemamy, MD is currently running
Nephroureterectomy With and Without Lymph Node Removal
for Bladder Cancer
The goal of this study is to conduct the first randomized-controlled trial to determine the oncologic efficacy of lymph node dissection in participants with upper tract urothelial cell carcinoma. The main questions it aims to answer are: * To determine oncologic outcomes, specifically 2-year recurrence-free survival * To determine other oncologic outcomes including treatment-free, cancer-specific and overall survival * To determine time to recurrence and recurrence patterns * To determine use of adjuvant therapies * To determine perioperative complications Participants will undergo nephroureterectomy with or without lymph node dissection. Researchers will compare these two groups to determine the oncologic efficacy of performing lymph node dissection.
Recruiting
1 award
N/A
Reconstructed Kidney Transplants
for Kidney Failure
This study is designed to investigate a novel approach to offer more ESRD participants the benefits associated with renal transplantation by increasing the supply of available allografts
Recruiting
1 award
N/A
1 criteria
More about Mohamed Eltemamy, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Mohamed Eltemamy, MD has experience with
- Lymph Node Dissection
- Nephroureterectomy
- Donor Radical And Partial Nephrectomy
- Kidney Transplantation
- Laparoscopic Radical Nephrectomy
Breakdown of trials Mohamed Eltemamy, MD has run
Transitional Cell Carcinoma
Renal Cell Carcinoma
Kidney Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mohamed Eltemamy, MD specialize in?
Mohamed Eltemamy, MD focuses on Transitional Cell Carcinoma and Bladder Cancer. In particular, much of their work with Transitional Cell Carcinoma has involved treating patients, or patients who are undergoing treatment.
Is Mohamed Eltemamy, MD currently recruiting for clinical trials?
Yes, Mohamed Eltemamy, MD is currently recruiting for 2 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Mohamed Eltemamy, MD has studied deeply?
Yes, Mohamed Eltemamy, MD has studied treatments such as Lymph Node Dissection, Nephroureterectomy, Donor Radical and Partial Nephrectomy.
What is the best way to schedule an appointment with Mohamed Eltemamy, MD?
Apply for one of the trials that Mohamed Eltemamy, MD is conducting.
What is the office address of Mohamed Eltemamy, MD?
The office of Mohamed Eltemamy, MD is located at: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio 44195 United States. This is the address for their practice at the Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.